Pure Global

Effect of Acetazolamide on Optic Nerve Sheath Diameter in Laparoscopic Donor Nephrectomies - Trial NCT03005665

Access comprehensive clinical trial information for NCT03005665 through Pure Global AI's free database. This phase not specified trial is sponsored by Postgraduate Institute of Medical Education and Research and is currently Completed. The study focuses on Intracranial Pressure Increase. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT03005665
Completed
drug
Trial Details
ClinicalTrials.gov • NCT03005665
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Acetazolamide on Optic Nerve Sheath Diameter in Laparoscopic Donor Nephrectomies
Effect of Orogastric Acetazolamide on Intraocular Pressure in Laparoscopic Donor Nephrectomies

Study Focus

Acetazolamide

Interventional

drug

Sponsor & Location

Postgraduate Institute of Medical Education and Research

Chandigarh, India

Timeline & Enrollment

N/A

Feb 01, 2016

Dec 01, 2016

40 participants

Primary Outcome

Change in Optic nerve sheath diameter being assessed

Summary

The purpose of the trial is to study the effect of acetazolamide administered via Ryle's tube
 on optic nerve sheath diameter in laparoscopic live donor nephrectomy patients.

ICD-10 Classifications

Benign intracranial hypertension
Intracranial injury
Intracranial injury, unspecified
Other intracranial injuries
Intracranial hypotension following ventricular shunting

Data Source

ClinicalTrials.gov

NCT03005665

Non-Device Trial